Date on Master's Thesis/Doctoral Dissertation
Pharmacology and Toxicology
Pharmacology and Toxicology, MS
Committee Co-Chair (if applicable)
HIV; biotechnology; drug development; lectin; antibody; plant-based protein expression
This thesis describes the development of a novel lectin-Fc fusion protein and its antiviral and anti-cancer activity. The molecule, Avaren-Fc (AvFc), is a fusion of a variant of the actinomycete lectin actinohivin (Avaren) and the Fc region of human IgG1, and is selective for the terminal α1,2-mannose residues found at the ends of high-mannose-type glycans that can be found on the surface of certain heavily glycosylated viruses and cancer cells. Here, AvFc was found to be able to neutralize simian immunodeficiency virus as well as Hepatitis C virus with nanomolar IC50 values. Furthermore, AvFc recognizes a number of cell surface receptors and is capable of protecting mice against lung and flank B16F10 challenges primarily through Fc-mediated mechanisms. This work builds upon the framework developed by our group supporting the preclinical development of AvFc as a novel antiviral and anti-cancer protein.
Dent, Matthew William, "Development of a lectin-Fc fusion protein with antiviral and anti-cancer activity." (2019). Electronic Theses and Dissertations. Paper 3237.
Amino Acids, Peptides, and Proteins Commons, Biotechnology Commons, Macromolecular Substances Commons, Molecular Biology Commons, Other Immunology and Infectious Disease Commons, Other Plant Sciences Commons, Pharmaceutics and Drug Design Commons, Pharmacology Commons